Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04834921
Status:
COMPLETED
Last Update Posted:
2021-04-12
First Post:
2021-03-30
Brief Title:
MCO Membrane Efficiency in Septic Shock Patients
Sponsor:
Fiorenza Ferrari
Organization:
Fondazione IRCCS Policlinico San Matteo di Pavia
Study Overview
Official Title:
Randomized Blinded Controlled Pilot Study on Clinical Assessment of Continuous Hemodialysis With a High Molecular Flux Membrane
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a monocentre randomized pilot study All patients received two consecutive RRT CVVHD with MCO filter Ultraflux EMiC2 and post-Continuous Veno-Venous Hemodiafiltration CVVHDF with HFFAV1000S in a controlled randomized 11 blinded manner Crossover randomized to sequence AB or BA for 48 h total without washout
Detailed Description:
This is a monocentre randomized pilot study All patients received CVVHD with MCO filter Ultraflux EMiC2 and post-Continuous Veno-Venous Hemodiafiltration CVVHDF with HFFAV1000S in a controlled randomized 11 blinded manner Crossover randomized to sequence AB or BA for 48 h total without washout
The efficiency of the filters for small and middle molecules was compared in septic shock patients with AKI stage 3
The efficiency of the filters for small and middle molecules was compared in septic shock patients with AKI stage 3
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None